UrSure Inc.
Medtech · Private
Point-of-care diagnostic test measuring Tenofovir Diphosphate to monitor long-term adherence to HIV PrEP and antiretroviral therapy
- Grants
- $7.1M
- 9 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 8
- 1 granted · 7 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201620172018201920202021
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · A Point of Care Test to Monitor and Promote Adherence to PrEP for HIV Prevention | $220,223 | |
| Federal grant | Department of Health and Human Services · Phase II · A Point of Care Test to Monitor and Promote Adherence to PrEP for HIV Prevention | $613,679 | |
| Federal grant | Department of Health and Human Services · Phase II · A Point of Care Test to Monitor and Promote Adherence to Tenofovir-based regimens for the Prevention and Treatment of HIV | $2,585,060 | |
| Federal grant | Department of Health and Human Services · Phase II · A Point of Care Test to Monitor and Promote Adherence to PrEP for HIV Prevention | $151,500 | |
| Federal grant | Department of Health and Human Services · Phase II · A Point of Care Test to Monitor and Promote Adherence to PrEP for HIV Prevention | $886,139 | |
| Federal grant | Department of Health and Human Services · Phase I · A Point of Care Test to Monitor and Improve Adherence to Dolutegravir for HIV Treatment | $224,874 | |
| Federal grant | Department of Health and Human Services · Phase II · A Point of Care Test to Monitor and Promote Adherence to Tenofovir-based regimens for the Prevention and Treatment of HIV | $933,742 | |
| Federal grant | Department of Health and Human Services · Phase II · A Point of Care Test to Monitor Long-Term Adherence to Tenofovir-based Regimens For The Prevention and Treatment of HIV | $757,105 | |
| Federal grant | Department of Health and Human Services · Phase II · A Point of Care Test to Monitor Long-Term Adherence to Tenofovir-based Regimens For The Prevention and Treatment of HIV | $721,414 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1992 | mFluiDx, Inc. | — | — |
| 1993 | Therapeutic Articulations, LLC | — | — |
| 1994 | Axonova Medical LLC | — | — |
| 1995 | UrSure Inc. | — | — |
| 1996 | Sojourn MedTech LLC | — | — |
| 1997 | Vitaliti Technologies Inc. | — | $21K |
| 1998 | ARTANN LABORATORIES, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Products And Methods For Monitoring Adherence To Nucleoside Reverse Transcriptase Inhibitor Therapygranted
- System And Method For Detecting Therapeutic Agents To Monitor Adherence To A Treatment Regimenapplication
- System And Method For Detecting Therapeutic Agents To Monitor Adherence To A Treatment Regimenapplication
- Products And Methods For Monitoring Adherence To Nucleoside Reverse Transcriptase Inhibitor Therapyapplication
- System And Method For Detecting Therapeutic Agents To Monitor Adherence To A Treatment Regimenapplication
- Reagents, Methods, and Systems for Detecting Therapeutic Agents to Monitor Adherence to Nucleoside Reverse Transcriptase Inhibitorsapplication
- System And Method For Detecting Therapeutic Agents To Monitor Adherence To A Treatment Regimenapplication
- System And Method For Detecting Therapeutic Agents To Monitor Adherence To A Treatment Regimenapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.